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V(D)J recombination is responsible for the de novo creation of antigen receptor genes in T- and B-cell
precursors. To the extent that lymphopoiesis takes place throughout an animal’s lifetime, recombination errors
present an ongoing problem. One type of aberrant rearrangement ensues when DNA sequences resembling a
V(D)J joining signal are targeted by mistake. This study investigates the type of sequence likely to be subject
to mistargeting, the level of joining-signal function associated with these sequences, and the number of such
cryptic joining signals in the genome.
In a vertebrate, many millions of B and T cells are produced
daily. A pivotal event in B- and T-cell differentiation is the
assembly, through DNA recombination, of antigen receptor
genes (reviewed in reference 43). Recombination is mediated
by two key proteins, called RAG1 and RAG2, as well as an
incompletely defined collection of other enzymes and factors
(reviewed in references 28 and 56). During pre-B-cell and
pre-T-cell development, DNA segments termed V, D, and J
are assembled to form the variable exon of the expressed
immunoglobulin (Ig) and T-cell receptor (TCR) genes. The
joined gene segments encode the highly variable antigen-bind-
ing domain of the antigen receptor protein.
V(D)J assembly is accomplished through DNA rearrange-
ments that can encompass up to several megabases. The se-
quence motifs that serve as recognition elements for this pro-
cess (joining signals) are surprisingly compact. A joining signal,
found adjacent to every V, D, or J segment, is comprised of a
heptamer (CACAGTG), a spacer (of 12 or 23 bp), and a
nonamer (ACAAAAACC) (Fig. 1A). No sequence apart from
the 28 (or 39)-bp joining signal motif is required for site-
specific recognition and recombination (reference 33 and ref-
erences cited therein).
Any V(D)J recombination event is normally an interaction
between two gene segments, one of which possesses a 12-bp
spacer (12-spacer) signal, and the other of which possesses a
23-bp spacer (23-spacer) signal. The molecular signature of
V(D)J recombination is production of two types of junctions.
One of these, the coding joint, is formed from the fusion of the
two coding sequences (e.g., V and J), and the other, a signal
joint, is formed from the corresponding joining signals. It is
usual for a coding joint to have a small and variable degree of
base loss and insertion at the point where the two coding
elements connect, whereas the signal joint is typified by a
precise fusion, heptamer to heptamer, of the two signals.
Not surprisingly, DNA sequences that resemble an authentic
joining signal (cryptic signals) are sometimes rearranged by
mistake (first described in reference 36). The result is the
production of recombinant junctions that are structurally anal-
ogous to coding joints and signal joints (Fig. 1) (17, 36). In this
report, we take production of the characteristic junctions as the
defining, diagnostic feature of a cryptic signal.
Cryptic signals are seen at several of the Ig and TCR loci in
both mice and humans and are active in recombination with
authentic V, D, or J joining signals. Most of these sequences
make no positive contribution to antigen receptor gene assem-
bly because they are not associated with any V, D, or J coding
sequence. An earlier suggestion that certain cryptic signals
played a role in T- or B-cell development, through the recom-
binational silencing of an Ig or TCR locus, is now considered
unlikely (20, 53). Although recombination of a cryptic signal
located within the coding sequence of many Vh genes may play
a role in receptor editing (for a recent discussion, see reference
14), it is probable that most observed cryptic rearrangements
are simply a by-product of the activation of V(D)J recombina-
tion enzymes. In the context of the early T- and B-cell devel-
opmental programs, strong selections for a functional antigen
receptor (for reviews, see references 51 and 74) mean that the
consequences of an occasional cryptic signal rearrangement at
an Ig or TCR locus ought to be negligible.
At the same time, selective gates that sample the state of the
antigen receptor would not be expected to remove those pre-B
and pre-T cells that have acquired cryptic rearrangements at
non-Ig/TCR loci. The fact that cryptic rearrangement can oc-
cur completely apart from the Ig and TCR loci has been well
established. Site-specific, recurrent rearrangements at two dif-
ferent locations are seen in human T cells (2, 11, 26, 27). Both
cases involve deletion and take place between a pair of rela-
tively closely linked cryptic sequences. In one instance, a 90-kb
deletion between the sil and scl genes on chromosome 1 (2, 11)
was detected in patients with T-cell acute lymphocytic leuke-
mia (T-ALL). In the other, specific deletions in the hypoxan-
thine-guanine phosphoribosyltransferase (hprt) gene (on the X
chromosome) were found in peripheral blood T cells of healthy
individuals (26, 27). In each example, the deletion junctions
exhibited all hallmarks of V(D)J coding joints (in particular,
some joints bore a very diagnostic type of sequence termed a P
insertion, and multiple independent deletions with nearly iden-
tical endpoints could be documented [see examples in refer-
ences 2, 7, 10, 11, 26, 27, and 37]). The deletion endpoints were
consistently found adjacent to DNA sequences bearing simi-
larity to a V(D)J joining signal. These data have provided the
most conclusive evidence to date for V(D)J targeting errors
involving sequences outside the Ig and TCR loci.
To more fully understand both the molecular and biological
imperatives associated with the problem of fidelity in V(D)J
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recombination, we have attempted to learn more about the
basic parameters governing cryptic signal rearrangement. We
have arrived at a minimum estimate for the number of cryptic
signals in the genome and have measured the relative joining
function intrinsic to several such sequences. Our results indi-
cate that cryptic signals are extremely numerous and exhibit
significant V(D)J target potential and thus must present a
profound challenge to joining fidelity.
MATERIALS AND METHODS
Cells. The Abelson murine leukemia virus transformant 204-1-8 (49) was used
in all experiments as previously described (42, 45, 50).
Transfections. Transfections were carried out as detailed by Lieber et al. (47).
Briefly, 3 3 106 cells were transfected with 150 ng of DNA in a protocol including
DEAE-dextran and osmotic shock. Plasmid DNAs were recovered from the
transfected cells at about 48 h by an alkaline lysis procedure and introduced into
Escherichia coli (33).
Identification of spontaneously arising cryptic recombinants. Some cryptic
recombinants were deliberately isolated during surveys for rare V(D)J recombi-
nation products (42, 45, 50). A general method is summarized below. In other
investigations, cryptic recombinants were discovered by chance among chloram-
phenicol-resistant colonies. In still other studies, chloramphenicol (rather than
ampicillin)-resistant colonies were screened as described below (reference 50
and unpublished data).
In outline, cryptic signals were identified in two steps: first, putative cryptic
recombinants were isolated; and second, the DNA sequence of the junction was
inspected. Attributes described below determined whether a particular rear-
rangement was related to V(D)J joining and established the identity of the
involved cryptic signal.
Many cryptic recombinants were isolated by using extrachromosomal sub-
strates in which the last base pair of the joining signal constituted the first base
pair of an adjacent, unique restriction site (Fig. 2). To isolate 23-spacer signal-
specific rearrangements in a way that would include rare classes of site-specific
recombinant (as illustrated in Fig. 2), plasmid DNA was treated posttransfection
with BamHI. The digested DNA was used to transform E. coli, and filter lifts of
ampicillin-resistant colonies were hybridized to an oligonucleotide spanning the
signal/flank border of an unrearranged 23-spacer signal (Fig. 2) (42, 45). All
hybridizing colonies were disregarded, and the nonhybridizing colonies (having a
deleted or interrupted region corresponding to the specific oligonucleotide
probe) were picked and regrown in replicate grid arrays. These isolates were
crudely mapped by testing their hybridization to the panel of oligonucleotides
diagrammed in Fig. 2. Candidate cryptic recombinants were any that did not
exhibit the expected hybridization pattern for a standard, hybrid, or open-and-
shut joint (Fig. 2).
Possible cryptic recombinants were further analyzed by treating miniprep
DNA with diagnostic restriction enzymes and categorized according to whether
they contained a signal joint (as in either a deletional signal joint or inversional
rearrangement) or only a coding joint.
(i) Signal joint-containing isolates (with inversion or deletion). Either ApaL1
or HgiA1 can cleave the sequence GTGCAC, which is created upon the forma-
tion of most signal joints. Two distinct bands are observed for a recombinant
containing a joint between the authentic 12-spacer signal and the authentic
23-spacer signal. The presence of one of the two bands, in the absence of the
other, was taken to indicate an isolate containing a cryptic signal joint. If a
variant pattern had not previously been noted, isolates were subjected to DNA
sequence analysis to verify that a novel cryptic element had become site-specif-
ically attached to the heptamer of an authentic joining signal (as shown in Fig.
1B). For inversional recombinants, the DNA sequence of at least one example of
a coding joint was determined in addition to the signal joint.
(ii) Coding-joint-containing isolates. The ApaL1 or HgiA1 banding pattern is
not informative if a coding joint has been formed by deletion (or if a signal joint
has been formed from a cryptic signal lacking CAC at its heptamer border). For
isolates whose recurrent restriction patterns lacked the ApaL1 (or HgiA1) bands
diagnostic of a signal joint, DNA sequence analysis was performed. Junctions
that met the following criteria were considered to be cryptic coding joints: (i)
inspection of the nonrecombinant precursor indicated that a properly oriented
CAC sequence (deleted in the recombinant) lay, at most, several base pairs from
the recombination site; (ii) for the canonical partner signal, the crossover site was
positioned normally, that is, at most a few base pairs displaced away from the
heptamer edge to the side opposite from the nonamer; and (iii) at least two
different coding joints involving the same putative cryptic sequence were iso-
lated. In one case, a single joint fulfilling the first two criteria was accepted
because it contained a 2-bp P nucleotide insertion (see the legend to Fig. 1 for
definition; reviewed in reference 44). P insertions of greater than one nucleotide
are sufficiently rare (50) to be considered diagnostic.
Any signal joint recombinant in which the cryptic signal lacked CAC at its
heptamer edge would have been among the isolates subjected to DNA sequence
analysis. No examples were found.
(iii) Parental plasmids and specific protocols. The approximately 8-kb plas-
mids from which the cryptic signals were isolated all had a 7,637-bp region in
common. The plasmids varied in the following features: the presence or absence
of the oop transcription terminator of bacteriophage l, the presence of an
overlapping restriction site at one or both joining signals, the presence or identity
of a nonoverlapping restriction site flanking one or both joining signals, the
presence, identity, or orientation of the 12-spacer signal, and the identity of 2 bp
at positions 6130 and 6131 (34). All of the differences between plasmids were
FIG. 1. Functional definition of a cryptic signal. (A) Cartoon of a cryptic rearrangement. A cryptic joining signal (dotted triangle) acts as a 12-spacer signal in a
recombination with a canonical 23-spacer joining signal (shaded triangle shown attached to the J segment). The sequence flanking the cryptic signal is shown as a box
for convenience but does not represent any specific element. Two products are formed: a cryptic coding joint (dotted and shaded boxes) and a cryptic signal joint (dotted
and shaded triangles). Recombination between a pair of cryptic sequences is also possible but is not illustrated. (B) Sequence characteristics of recombinant junctions.
For illustration, an arbitrary sequence is shown in lowercase letters flanking an unspecified cryptic signal (uppercase X’s); likewise, an arbitrary sequence in lowercase
represents the segment adjacent to the canonical signal (uppercase). The cryptic coding joint is variant and exhibits an irregular loss and addition of the sequences
formerly flanking the two signals. One hypothetical junction is shown, with P and N insertions as indicated. P insertions occur adjacent to untrimmed coding flanks only
and, as illustrated, comprise an inverted repeat of the terminal one to several base pairs of sequence. A precise heptamer-to-heptamer fusion of the cryptic signal to
the canonical signal forms the cryptic signal joint.
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confined to an approximately 415-bp region; the remaining 7,637 kb of the
recombination substrates were identical.
Specific cryptic recombinants used to establish the DNA sequences of indi-
vidual cryptic signals were derived as detailed below; however, most cryptic
signals were recovered in more than one experiment: 7451, 6131 (p12323 [45]);
1632, 3762, 6912, and 7451 (hybrid joint) (pMut2 [50]); 5145 (pMut27 [50]);
1318, 2213, and 5865 (pMut7 [41a], which is identical to pJH288 except for the
12-spacer signal, which is identical to that of pMut2; cryptic signals were isolated
as described for pMut2); 77 and 6069 (pD16 [45, 68a]); 1947 (pSILSJD [this
report]); 1318 and 5145 (p6131inv [identical to p6130SJD save for the orientation
of the 6131 sequence in site 1] [unpublished]); and 2213 (p6130SJD [this report;
see below]). The signals 6131 and 1318 were originally identified by Joanne
Hesse (National Institutes of Health). It was found upon DNA sequence analysis
that cryptic sites 2213, 5145, and 5865 were rearranged in recombinants inde-
pendently isolated by Joanne Hesse and kindly provided by her.
Oligonucleotide probes. The oligonucleotides indicated in Fig. 2 were as fol-
lows: A is LAC-1, B is TER-1, C is TER-2, D is JH33 (42, 45), and 12 and 23 are
oligonucleotides that hybridize to 15 nucleotides spanning the joining-signal
borders as shown (45). An additional probe sometimes used in mapping was 7453
(CGTTGTGTAGGTACC [not shown]).
Other oligonucleotides, indicated in Fig. 6, were the X oligonucleotides spe-
cific for each construct plus E and F. E (6130SIG in reference 45) spanned the
signal/flank border of the 6131 signal as situated in site 2. The F oligonucleotide
hybridized to a sequence in the site 1-to-site 2 interval and had the sequence
TCCTAACAGCTATGACCATG. The construct-specific X oligonucleotides
were O/6131SJD (ATGTTGTGTCGACTC), O/WTSJD (CCACTGTGTCGAC
TC), O/6912SJD (CTGGAGTGTCGACTC), O/SILSJD (GCAGAGTGTCGAC
TC), and O/HPRSJD (TGTGTGTGTCGACTC).
Standardized recombination substrates and assay. Extrachromosomal V(D)J
recombination substrates for the standardized joining assay (Fig. 6 and 7) were
constructed by ligation of a double-stranded oligonucleotide cassette bearing
SalI-compatible termini to SalI-digested p23-only DNA (45). For each sequence
listed below, G on the left and TCGAC on the right of the insert constitute the
vector-derived, interrupted Sal site. For clarity, nonamers and heptamers are under-
lined. The recombination substrates were as follows: pWTSJD (canonical; GTCGA
GGTTTTTGTTCCAGTCTGTACCACTGTGTCGAC); p6131SJD (6131; GTCG
AACTTTATGCTTCCGGCTCGTATGTTGTGTCGAC); p6912SJD (6912; GTC
GAACTGAAACGTTTTCATCGCTCTGGAGTGTCGAC); p5145SJD (5145;
GTCGATCTTTTCTACGGGGTCTGACGCTCAGTGTCGAC); pHPRSJD
(Hpr-3a; GTCGATGTATTTGTGTGTGTGTGTGTGTGTGTGTCGAC);
pSILSJD (Sil-1; GTCGAAACTGATCCCTTACTACGTAGCAGAGTGTCGA
C); and pCASJD (CA repeat; GTCGATGTGTGTGTGTGTGTGTGTGTGTG
TGTGTCGAC). For each construction, the insert was confirmed by DNA
sequence analysis.
Recombination substrates were transfected into the cell line 204-1-8 as de-
scribed above except that caffeine was routinely included in the medium post-
transfection. As shown by others (52), 1 mM caffeine (ICN Biomedicals, Inc.)
increased the recovery of recombinants in the extrachromosomal assay. Caffeine
did not affect the ratios between various classes of recombinants (see the ap-
pendix).
In the standardized recombination assay, at least 100 and, as necessary, more
than 600 chloramphenicol-resistant colonies were picked to replicate grids. The
ratio of site 1 recombinants to site 2 recombinants was then determined. Site 1
recombinants were positive for probes A, E, F, and D; site 2 recombinants were
positive for A and D only (42, 45). Routinely, probes A, E, F, and C were used
to determine site 1 and site 2 recombinants. In early experiments, probe D and
an oligonucleotide specific for the unrecombined signal (X) of the given con-
struct were used as well but proved redundant (chloramphenicol-resistant colo-
nies were always positive for probe D, and use of the other probes in combination
never gave results that were discrepant with X). When randomly selected colo-
nies designated site 1 and site 2 recombinants according to hybridization analyses
were subjected to HgiA1 or ApaL1 DNA digestion, all proved to be of the
predicted structure. Additionally, DNA preparations from any candidate colony
that could not be unambiguously assigned to the site 1 or site 2 category on the
basis of hybridization analyses were subjected to diagnostic restriction analysis.
For each construct, the DNA sequence of at least one site 1 recombinant was
determined.
RESULTS
Cryptic signals within extrachromosomal V(D)J recombina-
tion substrates. To assess the frequency with which potential
V(D)J joining targets arise by chance within a defined DNA,
we counted cryptic joining-signal sequences in an extrachro-
mosomal V(D)J recombination substrate. A representative
construct as originally developed by Hesse et al. (33, 34) and
Lieber et al. (47) is shown in Fig. 2. The extrachromosomal
plasmid and related derivatives contain joining signals posi-
tioned so that site-specific rearrangement will disable a pro-
karyotic transcription terminator through deletion or inversion
(Fig. 2). This DNA is transfected into immortalized mouse
pre-B cells that are active for V(D)J recombination. After 2
days, the plasmid DNA is reisolated and is introduced into E.
coli. A chloramphenicol selection allows recovery of the re-
combinant molecules in the population (33, 34).
Unintended rearrangements are also recovered with this
assay (34). We found that cryptic recombinants were particu-
larly evident in studies where the assay was adapted to retrieve
low-level hybrid and open-and-shut junctions (Fig. 2) (42, 45).
We took advantage of this circumstance to collect all examples
where a joining signal had recombined with a cryptic sequence
FIG. 2. Detection of cryptic signals within extrachromosomal V(D)J joining
substrates. At the top is a diagram of a representative extrachromosomal V(D)J
joining substrate, p12323 (45). An example of a cryptic signal embedded in the
vector backbone is represented as a dot-filled triangle. The DNA segments
adjacent to the canonical 12- and 23-spacer joining signals are shown as boxes but
do not represent any specific element. Unique restriction sites for SalI and
BamHI overlap the joining signals by one nucleotide. Bars labeled A to D, 12,
and 23 represent oligonucleotides used as hybridization probes (not to scale). Pr,
stop, cat, and amp are, respectively, the bacterial promoter, a transcription
terminator, the chloramphenicol acetyltransferase coding sequence, and a com-
plete, constitutively expressed b-lactamase gene (33). The eukaryotic polyoma-
virus (py) early region is also indicated. Panels A to D show different V(D)J
joining products along with their hybridization properties. Outcomes A to C all
arise when canonical joining signals are targeted. The standard V(D)J recombi-
nation products (outcome A) are a coding joint (CJ) and a signal joint (SJ).
Alternative products are a hybrid joint (HJ [B]) or an open-and-shut joint (O&S
[C]). Panel D gives an example of the outcome when a cryptic signal is targeted
and shows a cryptic signal joint (analogous to the signal joint shown in panel A).
Cryptic recombinants are distinguished by their anomalous hybridization prop-
erties, which, though varied, are inconsistent with those of the recombinants
shown in panels A to C; for details, see Materials and Methods.
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over several years’ time. Details are given in Materials and
Methods.
Where a recombinant plasmid appeared to have been rear-
ranged by V(D)J mistargeting events, closer inspection deter-
mined whether defined structural and functional criteria were
met. As shown in Fig. 3, if an authentic joining signal recom-
bines with a cryptic sequence, there are three possible out-
comes. The resulting plasmid may contain either a signal joint,
a coding joint, or both. If (as shown in Fig. 3B and C) rear-
rangement results in retention of a signal joint, it is a fairly
simple matter to determine the DNA sequence of the novel
junction and by this means to directly identify the cryptic signal
(Fig. 1, 3B, and 3C). However, in cases where a coding joint,
having been formed by deletion, is the only plasmid-retained
V(D)J joining product (Fig. 3D), the identity of the cryptic
signal must be deduced indirectly from the recombinants. In
such cases, it is crucial to distinguish putative cryptic coding
joints from illegitimate rearrangements arising through unre-
lated mechanisms.
To maximize confidence in coding joint data, it is almost
always necessary to have multiple, slightly variant examples
available for analysis (Fig. 3D). In a cryptic coding joint (Fig.
1B, 3B, and 3D), two coding ends, one terminating within
several base pairs (and to the proper side) of an authentic
joining signal and the other likewise terminating near a candi-
date cryptic signal, are connected. Variable truncation should
be evident among cryptic coding joints arising from misrecog-
nition of a given cryptic sequence. Junctional insertions should
have the characteristics of either an N or a P region (reviewed
in references 43 and 44). N insertions are short, GC-rich, but
otherwise random additions; P insertions are inverted repeats
of one to several base pairs of the terminal residues of a
nontruncated coding end (a hypothetical example is shown in
Fig. 1). In practice, we have found that putative coding joints
generally satisfy either all of the above criteria or none of
them. For example, short (e.g., 4- to 10-bp) direct repeats are
not characteristic of V(D)J coding joints (62), and such inserts
were found within junctions that occurred no more than once
and had crossover sites inconsistent with a V(D)J joining prod-
uct (not shown).
Altogether, 14 cryptic signals were identified (Fig. 3 and 4).
Eleven of these were established on the basis of signal joint
data, and three were established on the basis of coding-joint for-
mation. Three other coding-joint-type recombinants, though
otherwise acceptable, were each isolated only once, and so the
corresponding cryptic signals have not been listed. The pUC-
based polyomavirus shuttle vector plasmid was composed of
eukaryotic, prokaryotic, and completely synthetic DNA, with
an overall GC content of 48%. There are no repetitive stretches
or unusual structural features that would make this DNA ob-
viously unsuited as a generic sequence.
Thus, in this representative DNA of roughly 8 kb, the oc-
currence of cryptic signals is, on average, at least one per 600
bp. The number of cryptic signals that we were able to find is
doubtless less than the actual number present, because the
constraints of the assay system are such that, for detection, a
recombinant molecule must be minimally able to confer am-
picillin resistance to E. coli and to replicate in both E. coli and
mouse cells.
Features of cryptic signals derived from the extrachromo-
somal substrate. To evaluate the sequence features of the
cryptic signals, they were aligned according to a spacer length
of exactly 12 or 23 bp. Such alignment showed that each cryptic
signal varied substantially from the canonical joining signal
sequence. Typically, only about 9 of the 16 canonical heptamer
and nonamer nucleotides were present in a cryptic sequence
(Fig. 4A, ALL). Identities were inconsistent from one se-
quence to the next. The only exception to this generality was
that every cryptic signal had CAC at positions 1 to 3 of the
heptamer. (As described in Materials and Methods, cryptic
signals lacking CAC1–3 were less likely to be detected, but were
not systematically excluded).
Remarkably, despite the individual variation, a consensus
DNA sequence derived from the aligned sequences very nearly
reconstructed the canonical V(D)J joining signal. The consen-
sus and canonical sequences are identical (with two ambigu-
ities) at 13 of 16 positions (Fig. 4B). For comparison, if one
were to assume an incorrect spacer length for each cryptic
signal (i.e., 23 instead of 12 bp and 12 instead of 23 bp), the
new consensus nonamer has no resemblance to the canonical
sequence (Fig. 4C).
These observations are considered further, with respect to
the targeting problem in V(D)J joining, in Discussion.
Cryptic signals in the genome. Using the criteria that were
applied to the plasmid-derived cryptic signals, we compiled a
list of naturally occurring cryptic signals from the human and
mouse genomes (Fig. 5). That is, endogenously derived cryptic
signals were functionally defined, as documented by the for-
FIG. 3. Distribution and orientation of cryptic signals. (A) Cryptic signals are
named according to their locations on plasmid pJH288 (46) (roughly to scale).
Sequences that functioned as 12-bp joining signals are shown as white triangles;
those that functioned as 23-bp signals are shaded. The canonical 12- and 23-bp
signals are located at 6210 and 6496. To the right in panel A, examples of the
three categories of cryptic rearrangement are indicated. D/SJ, deletion with
retained signal joint; D/CJ, deletion with retained coding joint; INV, inversion. In
panels B to D, examples of the data used to establish the identity of cryptic
signals are shown; e.g., the coding joints for signal 7451 are shown in panel D.
Junction sequences, with insertions, are indicated as in Fig. 1.
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mation of junctions with the appropriate structural character-
istics. The collection of sequences in Fig. 5 is, to the best of our
knowledge, a comprehensive listing of all published non-V-,
non-D-, or non-J-associated sequences observed to undergo
site-specific rearrangement. A DNA sequence was listed only if
it had been isolated in recombinant form as a signal joint [with
a typically precise connection to an authentic V(D)J joining
signal] or if the criteria specified above for coding joints (in-
cluding the existence of multiple isolates) were met.
When plasmid-derived cryptic signals were compared to
FIG. 4. Sequences and analysis of identified cryptic signals. (A) Cryptic signals from the plasmid backbone. The canonical joining-signal sequence is shown above
the line, and positions that are most critical to joining-signal function for in vivo recombination (1, 34) are shown in boldface. Cryptic signals, named as in Fig. 3, are
aligned below; in each case, nucleotides that match the canonical sequence are underlined. In the six adjacent columns are scored the identities to the canonical
heptamer (HEP), to the nonamer (NON), to the total (heptamer plus nonamer; ALL), to functionally important positions (IMP), and to A3–7 in the nonamer (A5).
The type of rearrangement is indicated in the column marked RRMT (Fig. 3): D/SJ (deletion with retained signal joint), D/CJ (deletion with retained coding joint),
and INV (inversion). (B) Consensus sequence for cryptic signals. The frequency of A, C, G, or T at each position is given. In the last line, a consensus for the cryptic
sequences is shown. Matches to the canonical sequence are underlined and in boldface. Ambiguities are noted. (C) Consensus nonamer sequence derived by using an
incorrect spacer length (12 bp in place of 23 bp or vice versa).
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those isolated from a physiological context, there were no
conspicuous differences between the two collections. In each
case, there were examples where fewer than half of 16 hep-
tamer and nonamer nucleotides matched an authentic joining
signal. The consensus sequences derived from the endogenous
collection and plasmid collections (Fig. 4B and 5C) were also
similar. For both, the most strongly conserved nucleotides lay
in the first four positions of the heptamer and within the A
FIG. 5. Naturally occurring cryptic signals. (A) All cryptic sequences, of genomic origin, reported to recombine with an authentic V(D)J joining signal (some
participate in cryptic signal-to-cryptic signal rearrangements as well). Some signals are renamed for convenience. In all cases, spacer lengths were taken as exactly 12
or 23 bp, regardless of the specified length in the original report [column marked (ref)]. Two nonamers are shown if a sequence is known to function as both a 23-spacer
signal and a 12-spacer signal in rearrangement with an authentic signal. In such cases, both nonamers were scored in panel C (and the heptamer was counted twice).
(H) indicates sequences from the human genome; other sequences are from the mouse. (B) Cryptic signals reported to recombine with other cryptic signals. A spacer
length of 12 or 23 bp is not certain for any of these signals, and it is possible that some sequences are bifunctional (10). Only the heptamer sequences were scored in
panel C. Column designations in panels A and B are as in Fig. 4; references are given in the last column. Consensus data (C) are displayed as in Fig. 4.
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tract of the nonamer. (The endogenous collection overall more
closely approximated the canonical sequence; this is likely a
reflection of the greater number of sequences in the collection
as well as the fact that some sequences, such as C-Ja [21],
clearly evolved from a real joining signal.) The similarity
between the two groups of cryptic signals indicates that the
sequences that we can identify with the extrachromosomal
recombination substrate are representative of those that re-
combine in vivo. This observation helps to establish the defined
substrate as an appropriate experimental model for V(D)J
target misrecognition. Further confirmation was obtained as
described below.
Joining potential of cryptic signal sequences. We wished to
determine the relative target functions of various cryptic se-
quences, compared to a canonical sequence, in a standardized
recombination assay. To this end, we prepared a set of com-
parably modified extrachromosomal V(D)J recombination
substrates that had been substituted with selected cryptic sig-
nals (Fig. 6). In the parental construct, an authentic 23-spacer
signal could join to either of two 12-spacer signals, positioned
at site 1 or site 2. Both site 1 and site 2 recombinants lead to
chloramphenicol resistance (Fig. 6, bottom).
Seven recombination substrates (pWTSJD, p6131SJD,
p6912SJD, p5145SJD, pHPR-3aSJD, pSIL-1SJD, and pCASJD)
differed from one another only in the identity of the site 1
sequence (as designated by the underlining). The signal at site
2 was invariant and served as an internal standard. The differ-
ent constructs were singly transfected into cells. The site 1/site
2 ratio for each was determined by picking large numbers of
chloramphenicol-resistant colonies to replicate grids and test-
ing hybridization to the indicated oligonucleotide probes (Fig.
7 and Materials and Methods).
Two aspects of the assay maximized sensitivity. One was that
the sequence serving as the invariant site 2 standard was itself
a cryptic signal, 6131 (Fig. 3 and 4). By measuring joining
frequencies relative to a weak signal, roughly 100-fold fewer
colonies had to be picked for each determination. This effec-
tively extended the practical range of the assay 2 orders of
magnitude. In addition, very low levels of joining-signal func-
tion could be detected because the hybridization analyses al-
lowed us to screen out all background chloramphenicol-resis-
tant colonies (as arise from illegitimate rearrangements as well
as cryptic recombination to the sites in the vector backbone).
The hybridization screen, though time-consuming, allowed
measurement of joining activity well below previous limits of
1% of wild-type activity (34). The site 2 standard has previously
been used as an internal control in other studies, and the
frequency with which site 2 recombinants are recovered is
independent of the presence or absence of a joining signal at
site 1 (45).
To establish the absence of any gross bias in site 1 and site
2 recombination, we first constructed a plasmid in which 6131
was present at both positions. As expected, the site 1/site 2
ratio was close to 1:1 (p6131SJD [Fig. 7]). The site 1/site 2 ratio
was then measured for the construct containing the canonical
12-spacer signal sequence at site 1. In this construct, the site
1/site 2 ratio was 94:1. Thus, the 6131 sequence, here used as
our standard, had approximately 1% of the activity of an au-
thentic joining signal.
With this information, we compared recombination function
for three plasmid-derived cryptic signals, two human-derived
cryptic signals and one synthetic sequence (a CA repeat) to
that of the canonical signal.
Cryptic signals exhibited widely different V(D)J joining
function (Fig. 7). While the 6131 sequence functioned at about
1% of wild-type levels, and a second plasmid sequence (5145)
FIG. 5—Continued.
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scored about fivefold lower, a third (6912) functioned below
the practical limits of the assay at ,0.003%. The relative join-
ing activities of the human genome-derived sequences showed
similar spreads: HPR-3a was very active at 3% of wild-type
levels, but the activity SIL-1 was far lower, at 0.002%. In fact,
as noted in Fig. 7, we recovered only one SIL-1 recombinant,
which was confirmed by DNA sequence analysis, upon screen-
ing over 600 site 2 recombinants from four transfections. This
result demonstrated that cryptic sequences scoring on the or-
der of 1025 in our assay can have an impact in a physiological
context (2, 11).
We also tested the joining activity of a sequence composed
of 14 CA repeats. CA repeats are preferentially found in eu-
chromatin and are present in an estimated 50,000 to 100,000
copies in the genome (67). This simple repeat had significant
activity in the assay, functioning relative to a canonical joining
signal at 0.6%.
In summary, the plasmid-derived cryptic sequences are both
structurally and functionally like sequences that are subject to
mistargeting by the V(D)J joining machinery in the human
genome. As mentioned above, the 14 cryptic signals that we
have been able to identify are doubtless only a subset of the
cryptic signals that exist within the 7.6-kb DNA. By simple
extrapolation from the plasmid data, at least 10 million se-
quences with intrinsic V(D)J target function exist in a mam-
malian genome of roughly 6 3 109 bp. By comparison to a
canonical joining signal in a standardized assay, the joining
potential of a significant fraction of these sites is likely within
severalfold of the 1% level.
DISCUSSION
V(D)J recombination is an obligatory part of T- and B-cell
development and is apparently ongoing throughout life (55).
As such, the impact of V(D)J recombination errors can be
considered on three levels: the single cell, the immune system,
and the animal. At the level of the single cell, those T- and
B-cell precursors in which cryptic signals rearrange are likely
culled (or not culled) by the same mechanisms that eliminate
T- and B-cell precursors where V(D)J joining has created
FIG. 6. The standardized test for joining-signal function. Seven versions of
the substrate shown were constructed for which the site 1 signal was the canon-
ical 12-spacer signal (as in pWTSJD) or was substituted with the 6131, 5145,
6912, HPR-3a, or SIL-1 sequence or a CA repeat sequence. The sole alteration
in these constructs was in the site 1 sequence. Signal joints (formed via deletion)
were measured. The heptamer-to-heptamer distance between site 1 and the
23-spacer signal is 253 bp, and that between site 1 and site 2 is 359. Both types
of recombinant are chloramphenicol resistant and are distinguished from one
another, and from other products, according to their hybridization properties.
Oligonucleotide probes are as in Fig. 1, with additional probes described in
Materials and Methods.
FIG. 7. Results with the standardized joining assay. Site 1 and site 2 recombinants were determined as described in Materials and Methods. At least four different
transfections were sampled for each determination. In the last column, results were normalized according to site 2 recombinants to give the joining function relative
to the canonical signal.
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nonfunctional out-of-frame variable exons (25, 51, 74). Unless
cryptic recombination is rampant, one would imagine that
there could be little negative impact on lymphopoiesis, because
the immune system is already set up to cope with the fact that
two-thirds of recombination attempts are out of frame. Mistar-
geting in V(D)J recombination is an altogether different sort of
problem, however, when viewed from the perspective of the
whole animal. A single mistake that activates an oncogene in
just one of the T- or B-cell precursors generated during the
animal’s lifetime can have a lethal outcome. There are quali-
tatively different constraints in force for this site-specific re-
combination system than for recombination systems (such as
lox/CRE or phage l integration) that operate in single-celled
organisms.
The type of V(D)J joining error investigated here is one in
which defined, characteristic recombinant junctions are formed
following misrecognition of a cryptic signal. Throughout, we
designate a DNA sequence as a cryptic signal on the basis of
functional criteria: it must be recognized, bound, brought to-
gether with a partner joining signal, cleaved, and successfully
reconnected by the V(D)J joining machinery.
Information provided by recent studies indicates that differ-
ent phases of recombination (binding, cutting, and complete in
vivo rearrangement) may require an overlapping but noniden-
tical set of DNA sequence features in a canonical joining
signal. With respect to binding, RAG1-joining signal interac-
tions have been measured, and more recently, a stable complex
that involves RAG1, RAG2, and the target DNA has been
described (23, 35, 66). The former studies highlighted nonamer
positions A5 and A6 (23, 66), whereas stable complex forma-
tion was affected by the identity of the last four heptamer
nucleotides (AGTG1–4) as well as the presence of the nonamer
(35). Somewhat different features govern the cleavage of join-
ing signals in vitro (19, 58). Here it has been shown that the
identity of the first three heptamer nucleotides (CAC1–3)
greatly affects the efficiency with which double-strand breaks
can be introduced. The analysis showed that the nonamer
could be eliminated, but it clearly augmented in vitro cleavage
by purified RAG1 and RAG2. A single change in A6 of the
nonamer has the same effect as removing the nonamer identity
entirely (58). Finally, the importance of different positions
within the canonical joining signal for complete in vivo recom-
bination has been assessed in two large studies (1, 34). These
analyses showed that in the context of a wild-type sequence,
single base changes within CAC1–3 of the heptamer, or A5, A6,
or A7 of the nonamer (depending on the study), had the great-
est impact. As noted, the nucleotides that were found to be
functionally important for in vivo recombination corresponded
well to the best-conserved positions in authentic joining signals
in nature.
The analyses summarized above point to important features
in the joining signal but do not allow one to predict which
features most significantly affect V(D)J target function for a
degenerate, multiply mismatched sequence, nor do these stud-
ies allow an estimate of the number of cryptic signals that
might exist within a defined region of DNA.
Here, in a long-term analysis, we determined the minimum
number of fortuitous sites in a 7.6-kb DNA able to function as
an acceptable V(D)J recombination target. We validated the
approach in two ways: first by showing that the DNA sequences
identified in the plasmid backbone were similar in nature to
the sequences with cryptic signal function from the mouse or
human genome, and second by demonstrating that the level of
function of the plasmid-derived signals was comparable to
cryptic signals of endogenous origin. By extrapolation from the
plasmid data, we can therefore estimate that there are at least
10 million sites in the genome with a DNA sequence compat-
ible with joining-signal function.
What does it take to be a cryptic signal? (i) Heptamer and
nonamer identities. Comparison of the cryptic signals to the
canonical sequence showed that, apart from CAC1–3 of the
heptamer, no other nucleotide is consistently present (Fig. 4).
Seven positions previously highlighted as important to func-
tion, in vivo, for the canonical joining signal (CACA1–4 of
the heptamer and A5, A6, and A7 of the nonamer [1, 34]) ap-
pear together in only two cryptic signals in the plasmid collec-
tion (Fig. 4A, IMP). The same observations—conservation of
CAC1–3, marked variability, and few examples where all seven
of the functionally significant identities are present—apply to
the chromosomally derived cryptic sequences in Fig. 5 as well.
A CAC sequence, of itself, is unlikely to have significant
cryptic signal function, judging from the SIL-1 sequence, which
had seven canonical identities (CAC1–3 plus four others).
SIL-1 was an extremely weak joining signal and recombined at
approximately 2 3 1025 the canonical frequency (Fig. 7). As
discussed below, it is possible that the SIL-1 sequence repre-
sents a lower functional limit for cryptic signals with a physi-
ological impact.
Despite the variable identities found at positions other than
CAC in the cryptic signal collections, a consensus sequence
derived from this small collection closely approximated the
canonical joining-signal sequence. This was not necessarily ex-
pected, and we interpret the fact that the canonical joining-
signal sequence can be distilled from the cryptic sequences to
mean that sporadic matches existing throughout a cryptic se-
quence are functionally important.
(ii) Spacers in cryptic signals. All cryptic signal sequences of
either plasmid or genomic origin were analyzed on the basis of
a spacer length of either exactly 12 bp or exactly 23 bp. Exper-
imentally, binding, cleavage and in vivo V(D)J recombination
all are sensitive to the length of the spacer separating a canon-
ical heptamer and nonamer (1, 19, 34, 58, 73). We have no
definitive evidence that spacers do not vary in the case of cryp-
tic signals, but we think it unlikely because the nonamers de-
fined by a 11- or 21-bp spacer length were generally not more
highly matched than those defined by an exact 12- or 23-bp
spacing. Among all 28 possible noncanonical spacer align-
ments, we found only five alignments that increased nonamer
identity, and this could well have occurred by chance. It was
notable that in all but one of the five better-matched spacer
variants, the nonamers gained identities at less evolutionarily
conserved positions at the expense of an important (A6 or A7)
nonamer match (not shown).
(iii) The effects of coding-flank sequence. The nucleotides
just adjacent to a joining signal (comprised of V, D, or J coding
sequences in a real gene segment) are termed the coding flank.
Work with canonical joining-signal sequences has shown that
the identity of one to three nucleotides at the coding flank can
have an impact on the efficiency with which a canonical signal
becomes cleaved in vitro or recombined in vivo (9, 19, 24, 29,
58, 61, 63, 73).
According to these observations, it was of interest to exam-
ine whether coding-flank sequence might be an important ex-
trasignal determinant of cryptic signal identity. As can be seen
in Fig. 8, however, the DNA sequences adjacent to our cryptic
signals revealed no obvious bias, purine/pyrimidine pattern
(58), or other restriction. Both preferred and proscribed cod-
ing-flank dinucleotide sequences (as highlighted in other stud-
ies [29, 58, 63]) occurred within the small collection. Further,
two coding flanks differing in quality were sampled for the 6131
sequence in the construct p6131SJD. In this substrate, the site
1 coding flank was GA; at site 2, it was CA. Sadofsky et al. (63)
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have observed marked coding-flank preferences in connection
with a canonical joining signal in cells transfected with the
RAG1 D32 mutant (CA was relatively neutral, and GA was
strongly disfavored). Regardless, for p6131SJD, the site 2/site 1
ratio was nearly 1:1 (Fig. 7). At a first approximation, it would
appear that coding-flank sequence is not a dominant factor in
determining whether a DNA sequence will function as a cryp-
tic site.
In summary, although the consensus sequence derived
from cryptic signals would suggest that certain heptamer
and nonamer positions are more important than others (Fig.
4B and 5C), a wide spectrum of DNA sequences comprised of
CAC with additional, nonunique matches to the canonical
sequence are functional V(D)J joining targets. The existence
of an enormous population of cryptic signals with highly vari-
able combinations of identities in both heptamer and nonamer
elements is indicated.
Relative joining functions of identified cryptic signals. Two
human cryptic sequences were chosen for study because they
illustrated two quite different biological effects of cryptic signal
recognition and because it was anticipated that they might have
very different intrinsic joining-signal functions. Each is subject
to mistargeting in vivo but at very different apparent frequen-
cies within the human population. The SIL-1 sequence is site-
specifically rearranged (to one of several partner cryptic sig-
nals) in T-ALL (2, 11), which is a rare disease. Activation of
the scl gene (as caused either by sil/scl deletion or by other
mechanisms) is highly correlated with T-ALL, and only about
300 new cases of T-ALL are diagnosed per year in the United
States (reviewed in reference 30). The HPR-3a sequence, in
contrast, is recombined in an estimated one in 2 3 107 circu-
lating fetal or adult T cells, so it is likely that every individual
possesses some cells that are site-specifically rearranged at this
cryptic sequence (26, 27). As anticipated, the SIL-1 and
HPR-3a sequences functioned at very different levels in the
standardized V(D)J joining assay. The SIL-1 sequence was 2 3
1025 times as active as a canonical signal, while the HPR-3a
sequence had 3% of the activity of a canonical signal (Fig. 7).
Direct demonstration of signal joint formation formally docu-
mented cryptic signal function in both cases (each had been
defined previously on the basis of coding joint criteria only [2,
11]). The 1,000-fold difference in intrinsic joining-signal activ-
ity measured for SIL-1 and HPR-3a would seem to at least
partially account for the large apparent difference in occur-
rence of sil/scl and hprt deletions in human T cells.
We have estimated that there are about 10 million cryptic
sites in the diploid genome and here can make some state-
ments about relative target site function. Two representative
plasmid-derived cryptic signals (6131 and 5145), each possess-
ing the average number of matches to the canonical sequence,
roughly evenly distributed between heptamer and nonamer,
showed significant joining-signal function, 1% in one case and
0.2% in another (Fig. 7). On this basis, it seems plausible that
a substantial fraction of genomic cryptic sequences will possess
a joining potential in the range of 1%. Moreover, a CA repeat
sequence (present in 50,000 to 100,000 copies in the genome
[67]) was shown to have a joining activy of 0.6% (Fig. 7), and
a perfect heptamer (which should by chance arise in roughly
200,000 copies in the genome) devoid of any nonamer matches
has been reported to function at 0.6 or 5% in other studies (1,
34). By any measure, DNA sequences with the potential to
function around the 1% level are abundant. We can crudely
relate the level of function measured in the extrachromosomal
assay to rearrangement in a physiological context: as men-
tioned above, the HPR-3a sequence, with a 3% joining poten-
tial in the standardized assay, is rearranged in most (perhaps
all) humans (26).
These analyses indicate that the genome is riddled with
DNA sequences that have the potential to act as cryptic V(D)J
recombination targets, with an intrinsic joining potential within
a physiologically relevant range. The number of such sites
alone compels the question of how it is possible to limit joining
errors during T- and B-cell differentiation.
How is fidelity achieved? V(D)J recombination is controlled
through a carefully programmed regulation of RAG protein
levels and further by modulated changes in chromatin struc-
ture at the Ig and TCR loci (for recent discussions, see refer-
ences 60 and 68). Less is known, however, about the degree to
which the remainder of the genome (outside the Ig and TCR
loci) is or is not exposed to the V(D)J joining enzymes. The
hprt and sil/scl deletions (2, 11, 26, 27) have provided solid
evidence that accessibility to the V(D)J joining enzymes is not
strictly limited to Ig and TCR loci.
Conceivably, fidelity is governed by factors operating at a
level other than chromatin structure. Studies of trans (interho-
molog) V(D)J recombination in normal thymocytes indicate
that if two V(D)J joining signals are on different homologs,
recombination is demonstrably rare, occurring on the order of
1024 times the frequency of cis recombination (4). trans rear-
rangements are also observed in B-cell precursors that have
been transformed by a temperature-sensitive Abelson murine
leukemia virus; these arise at a low frequency at the nonper-
missive temperature and occur in violation of the 12/23 rule
(5). It is interesting that class switch recombination, another
type of developmentally regulated recombination in B-lineage
cells that is mechanistically distinct from V(D)J joining, can
occur quite readily in trans. For example, in a normal rabbit,
there is evidence of interallelic rearrangement in fully 3 to 7%
of IgA-expressing B cells (39). Favored interactions between
linked DNAs in V(D)J recombination is consistent with the
possibility that an active recombination machinery is present in
only a few fixed sites, rather than freely diffusible, and perhaps
is anchored prior to the onset of rearrangement. Other studies
have indicated that components of the V(D)J joining machin-
ery, particularly the RAG1 and RAG2 gene products, may be
tethered to the nuclear matrix (16, 18, 41). If there is indeed a
small arena within which both the machinery and the target for
V(D)J recombination must come together, this could ensure
FIG. 8. Analysis of coding-flank composition in identified cryptic signals.
Coding-flank sequences for each cryptic signal are given. See text for details.
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fidelity by greatly limiting the number of actively targeted cryp-
tic signals in the genome.
To what extent is cryptic rearrangement an unavoidable
accompaniment to V(D)J recombination? At present, this is
difficult to answer, because without specific molecular probes
(3, 20, 21, 32, 38, 57, 72) or a strong phenotypic selection (2, 11,
26, 27), cryptic rearrangements in a normal T- and B-cell
population are effectively invisible. One would expect that nat-
ural selection has long since eliminated cryptic signals with a
high probability of activating an oncogene through site-specific
rearrangement. However, the number and activity of cryptic
sequences in regions where such sequences have little patho-
genic potential (as within the hprt gene), or the number of
weak signals near oncogenic targets (as within the scl gene),
are for the moment, unknown.
Our results indicate that there is the possibility of cryptic
V(D)J recombination for virtually any introduced DNA that
may pass through the early T- and B-cell differentiation pro-
gram. This ought to be a concern when it comes to evaluating
the safety of certain gene therapy or DNA vaccination proto-
cols.
APPENDIX
Transfections of 204-1-8 cells with p12323 (45) and pWTSJD (Fig.
5) were carried out in the presence or absence of 1 mM caffeine in the
medium posttransfection (52). In our hands, as previously reported
(52), caffeine increased the number of recombinants recovered per
transfection by 5- to 10-fold (not shown). This was useful in the present
experiments, where we were interested in quantifying function for
weak joining signals. p12323 and pWTSJD are identical except for the
orientation of the 12-spacer signal in site 1. Both constructs contain the
cryptic 12-spacer signal, 6131, at site 2. All pictured recombinants (Fig.
A1) are chloramphenicol resistant. Transfections were carried out in
parallel with and without caffeine. About 100 recombinants were
picked, and the numbers of inversions, deletions, hybrid junctions, and
site 2 recombinants among them were determined. The values for site
1, site 2, and hybrid junctions for a given construct were not signifi-
cantly different with and without caffeine (by the x2 test, P . 0.3 for
values with either plasmid). For comparison between p12323 and
pWTSJD, values can be normalized to the number of site 2 recombi-
nants, and it is also evident from this comparison that inversion/dele-
tion ratios are the same with and without caffeine. The results indi-
cated that caffeine did not affect inversion/deletion ratios, the ratio of
cryptic and canonical rearrangements, or the ratio of hybrid and stan-
dard recombination.
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